Stocks & Investing
Thu, September 26, 2024
[ Thu, Sep 26th 2024
] - WOPRAI
Tue, August 27, 2024
[ Tue, Aug 27th 2024
] - WOPRAI
Thu, October 21, 2021
[ Thu, Oct 21st 2021
] - WOPRAI
Sun, August 1, 2021
[ Sun, Aug 01st 2021
] - WOPRAI
Fri, April 17, 2020
[ Fri, Apr 17th 2020
] - WOPRAI
Thu, November 30, 2017
[ Thu, Nov 30th 2017
] - WOPRAI
Fri, November 3, 2017
[ Fri, Nov 03rd 2017
] - WOPRAI
Fri, January 6, 2017
Fri, July 29, 2016
[ Fri, Jul 29th 2016
] - WOPRAI
Mon, February 23, 2015
[ Mon, Feb 23rd 2015
] - WOPRAI
Fri, February 22, 2013
[ Fri, Feb 22nd 2013
] - WOPRAI
Thu, February 21, 2013
[ Thu, Feb 21st 2013
] - WOPRAI
Thu, November 1, 2012
[ Thu, Nov 01st 2012
] - WOPRAI
Wed, August 1, 2012
[ Wed, Aug 01st 2012
] - WOPRAI
Wed, May 2, 2012
[ Wed, May 02nd 2012
] - WOPRAI
Raj Denhoy Reiterated (ABT) at Hold and Held Target at $120 on, Sep 26th, 2024
Raj Denhoy of Jefferies, Reiterated "Abbott Laboratories" (ABT) at Hold and Held Target at $120 on, Sep 26th, 2024.
Raj has made no other calls on ABT in the last 4 months.
There are 6 other peers that have a rating on ABT. Out of the 6 peers that are also analyzing ABT, 0 agree with Raj's Rating of Hold.
These are the ratings of the 6 analyists that currently disagree with Raj
- Adam Maeder of "Piper Sandler" Initiated at Buy and Held Target at $131 on, Thursday, September 19th, 2024
- Joanna Wiensch of "Citigroup" Maintained at Strong Buy with Increased Target to $127 on, Thursday, August 22nd, 2024
- Matt Miksic of "Barclays" Maintained at Buy with Increased Target to $143 on, Monday, July 29th, 2024
- Vijay Kumar of "Evercore ISI Group" Maintained at Buy with Decreased Target to $120 on, Tuesday, July 2nd, 2024
- Shagun Singh of "RBC Capital" Reiterated at Buy and Held Target at $125 on, Tuesday, June 4th, 2024
- David Roman of "Goldman Sachs" Initiated at Strong Buy and Held Target at $121 on, Thursday, May 30th, 2024
